For the Inventor, By the Inventor

Enter assignee name

Dublin, Ireland

Elan Corporation, Plc

USPTO Granted Patents = 67

CIPO Patents = 2

Trademarks = 3

Forward Citations = 8,981

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Donald E Panoz (20 out of 22 patents)

Edward J Geoghegan (15 out of 20 patents)

Joseph Gross (12 out of 77 patents)

4. Seamus Mulligan (12 out of 15 patents)

5. Izrail Tsals (7 out of 35 patents)

6. Daniel Joseph O'Mahony (7 out of 17 patents)

7. Randall T Sparks (6 out of 7 patents)

8. Gilad Lavi (5 out of 45 patents)

9. Paul Stark (5 out of 10 patents)

10. Niall M M Fanning (4 out of 4 patents)

11. John G Devane (4 out of 15 patents)

12. Kenneth Iain Cumming (3 out of 9 patents)

13. Haim Danon (3 out of 4 patents)

14. Owen I Corrigan (3 out of 6 patents)

15. Gilbert Corneille (3 out of 3 patents)

Core Competencies:

Lactam Compound

Multiparticulate Modified Release Composition

Peptide Drug Delivery System

Gastrointestinal Transport Receptors

Controlled Release Pharmaceutical Compositions

Subcutaneous Drug Delivery Device

Transdermal Drug Delivery

Taste-Masked Formulations

Intravenous Drug Delivery

Biodegradable Nanoparticles

Neurological Disease Treatments

Fluid Drug Flow Devices

67 patents: Sort by Forward Citations

1. 7468365 - Lactam compound (2008-12-23),

2. 7135457 - Random peptides that bind to gastro-intestinal tract (GIT) transport receptors and related methods (2006-11-14),

3. 6902742 - Multiparticulate modified release composition (2005-06-07),

4. 6830560 - Automatic syringe (2004-12-14),

5. 6793936 - Multiparticulate modified release composition (2004-09-21),

6. 6780846 - Membrane translocating peptide drug delivery system (2004-08-24),

7. 6730325 - Multiparticulate modified release composition (2004-05-04),

8. 6699973 - Antibodies to peptides that target GIT receptors and related methods (2004-03-02),

9. 6521737 - Peptides which enhance transport across tissues and methods of identifying and using the same (2003-02-18),

10. 6423334 - Composition and method for enhancing transport across gastrointestinal tract cell layers (2002-07-23),

11. 6399100 - Controlled release pharmaceutical compositions containing tiagabine (2002-06-04),

12. D455207 - Drug conversion device (2002-04-03),

13. 6361938 - Peptides which enhance transport across tissues and methods of identifying and using the same (2002-03-26),

14. 6346613 - Composition and method for enhancing paracellular transport across cell layers (2002-02-12),

15. 6346095 - Needle and method for delivery of fluids (2002-02-12),

Elan Corporation PLC is a biotechnology company that specializes in the research, development, and manufacturing of pharmaceutical products. They focus on neuroscience and specialize in therapies for neurological disorders such as Alzheimer's and Parkinson's disease.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

67 Patents

#26 in Dublin

#44 in Ireland

#10,618 in the World

Dublin, Ireland

Elan Corporation, Plc

Forward Citations = 8,981

56 inventors:

Donald E Panoz (20 out of 22 patents)

Edward J Geoghegan (15 out of 20 patents)

Joseph Gross (12 out of 77 patents)

4. Seamus Mulligan (12 out of 15 patents)

5. Izrail Tsals (7 out of 35 patents)

Please report any incorrect information to support@idiyas.com

Loading…